Ratiometric co-delivery of doxorubicin and docetaxel by covalently conjugating with mPEG-poly(β-malic acid) for enhanced synergistic breast tumor therapy
- 28 September 2020
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Polymer Chemistry
- Vol. 11 (46) , 7330-7339
Abstract
Codelivery of chemotherapeutic drugs using polymer–drug carriers represents a promising strategy to achieve ratiometric delivery and a synergistic effect in targeted tissues and cells, which will improve the therapeutic index and reduce the side effects as compared to traditional cancer combination chemotherapy. In this study, a novel biodegradable methoxy poly(ethylene glycol)-poly(β-malic acid) (mPEG-PLMA) nanoparticle is developed for the precise codelivery of two established drugs (doxorubicin and docetaxel) and hypothesized to act synergistically to improve the anticancer efficacy of the two drugs. Doxorubicin (DOX) and docetaxel (DTX) were covalently bound to mPEG-PMLA through a one-step coupling reaction with distinct linkers, resulting in mPEG-PMLA-DOX/DTX conjugates. The conjugates exhibited a significant synergistic inhibitory effect on human breast cancer cells MDA-MB-231 when the molar ratio of conjugated DOX/DTX was 1 : 1, with an IC50 value of about 0.62 μg mL−1 for DOX and 0.91 μg mL−1 for DTX, only accounting for 40% and 7% of the IC50 for free DOX and DTX, respectively. The results of the pharmacokinetic study show that the conjugates were capable of increasing the half-life (DOX with 1.7-fold and DTX with 3.3-fold) and AUC (DOX with 2.2-fold and DTX with 4.5-fold) and maintaining the synergistic drug ratio at the tumor site for over 24 h. Furthermore, the conjugate displayed more potent anti-tumor efficacy and lower systemic toxicity than the free drug combination in vivo. These results confirmed that the combinatorial delivery system could exhibit a fascinating prospect for the synergistic delivery of drugs with diverse physicochemical properties in cancer treatment integrating efficiency and safety considerations.Keywords
Funding Information
- National Natural Science Foundation of China (81571786, 31771087, 81271687, 31671015)
- Science and Technology Innovation as a Whole Plan Projects of Shaanxi Province (2015KTCL03-12, 2020TD-041)
This publication has 44 references indexed in Scilit:
- Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumorInternational Journal of Pharmaceutics, 2015
- Quantitative Analysis of PMLA Nanoconjugate Components after Backbone CleavageInternational Journal of Molecular Sciences, 2015
- An improved d-α-tocopherol-based nanocarrier for targeted delivery of doxorubicin with reversal of multidrug resistanceJournal of Controlled Release, 2014
- Synthesis of controlled molecular weight poly (β-malic acid) and conjugation with HCPT as a polymeric drug carrierJournal of Polymer Research, 2014
- Anthracyclines and taxanes in the neo/adjuvant treatment of breast cancer: does the sequence matter?Annals of Oncology, 2014
- Dysregulated pH: a perfect storm for cancer progressionNature Reviews Cancer, 2011
- Enhancement of docetaxel solubility via conjugation of formulation-compatible moietiesOrganic & Biomolecular Chemistry, 2009
- Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination StudiesPharmacological Reviews, 2006
- Polycefin, a New Prototype of a Multifunctional Nanoconjugate Based on Poly(β-l-malic acid) for Drug DeliveryBioconjugate Chemistry, 2006
- Poly(β-malic acid): obtaining high molecular weights by improvement of the synthesis routePolymer, 1996